Designing steriod receptor-based radiotracers to image breast and prostate tumors
Journal Article
·
· Journal of Nuclear Medicine
OSTI ID:250035
- Univ. of Illinois, Urbana, IL (United States)
Imaging of breast or prostate cancers based on their content of steroid receptors poses a major challenge in the design of radiotracers. Receptors for steroid hormones are proteins that interact at specific sites in chromatin. Several analogs of estrogens, progestins and androgens have been radiolabeled and evaluated both in vitro and in vivo for receptor binding affinity and selectivity. Breast tumors in patients have been imaged with [{sup 18}F]fluoroestradiol. Scintigraphic images with radiolabeled progestin analogs may be useful for monitoring the efficacy of tamoxifen treatment in breast cancer patients. Tissue distribution and imaging studies in animals with fluorine-substituted androgens indicate that it may be possible to develop a steroid receptor-based radiotracer for staging prostate cancer. Radiochemists are reporting some progress in labeling steroid receptor ligands with {sup 99m}Tc. By using the techniques of molecular nuclear medicine, new imaging procedures could be developed that might provide more precise information to help characterize disease and effect treatment decisions in patients with breast or prostate cancers. 55 refs., 4 figs., 4 tabs.
- OSTI ID:
- 250035
- Journal Information:
- Journal of Nuclear Medicine, Journal Name: Journal of Nuclear Medicine Journal Issue: 6 Vol. 36; ISSN JNMEAQ; ISSN 0161-5505
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radiolabeled androgens and progestins as imaging agents for tumors of the prostate and breast
PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging
Radiolabeled androgens and progestins as imaging agents for tumors of the prostate and breast. Technical progress report, February 1, 1992--January 31, 1993
Technical Report
·
Sat Aug 08 00:00:00 EDT 1992
·
OSTI ID:6853675
PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging
Journal Article
·
Thu Jul 23 00:00:00 EDT 2020
· Cancers (Basel)
·
OSTI ID:1800647
Radiolabeled androgens and progestins as imaging agents for tumors of the prostate and breast. Technical progress report, February 1, 1992--January 31, 1993
Technical Report
·
Sat Aug 08 00:00:00 EDT 1992
·
OSTI ID:10110956